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Summary Since the ﬁrst discovery, that ultrasound can overcome the skull allowing exam-
ination of the intracranial blood-ﬂow as well as the ﬁrst description of substantia nigra (SN)
signal alterations via B-mode sonography, a plethora of applications especially in the ﬁeld of
movement disorders have been fostered. Up to now, however, most studies investigated adultPediatric;
Movement disorder;
TCS
individuals, even though numerous of the diseases studied have their onset already during
childhood or adolescence. This overview summarizes recent studies of transcranial B-mode
sonography (TCS) within the movement disorder ﬁeld and outlines potential implications for
pediatric applications.
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History of transcranial ultrasound
For decades it was thought, that it is impossible to pene-
trate the intact scull by ultrasound for the visualization of
intracranial structures and measurement of blood ﬂow in
the circle of Wilis. It was in the 1980s when Aaslid et al.
could demonstrate that blood ﬂow of the intracranial arter-
ies can be analysed by transcranial Doppler sonography [1].
In following years a rapid development of ultrasound systems
evolved until Becker et al. were able to display the substan-
tia nigra (SN) reproducibly via B-Mode sonography in 1995.
Moreover, they were able to demonstrate an enlargement
and hyperechogenicity of the SN area patients suffering from
Parkison’s disease (PD) [2]. Up to now, this ﬁnding was repro-
Openduced by many independent groups and transcranial B-mode
sonography (TCS) developed into an expanding research ﬁeld
for amultitude of medical applications. Here, wewill shortly
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Open access under CC BY-NC-ND license.ighlight the different ultrasound implementations in the
edical ﬁeld and will focus on the most recent advances in
he diagnosis of movement disorders especially in children.
urrent applications in adults
pplications in Parkinson’s disease
n recent years, TCS has become widely accepted and
sed in the early and differential diagnosis of Parkinson’s
isease. One hallmark of this method, besides its inex-
ensiveness and non-invasive character, is the ability to
iscriminate between essential tremor, Parkinson’s disease
elated tremor and the differentiation of atypical Parkinson
yndromes [3—5]. In PD, the typical ﬁnding is a hypere-
hogenicity of the SN, which is normally more pronounced
s under CC BY-NC-ND license.ontralateral to the clinically more affected side [6]. This
yperechogenicitiy seems to stay constant during the course
f the disease and patho-anatomical investigations revealed
hat it most likely reﬂects increased iron content, as was
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hown in animal experiments, as well as in post mortem of
rains [7—10].
In patients with atypical signs in Parkinson syndromes TCS
s useful for assignment to the idiopathic forms. Patients
ith multi system atrophy, or supranuclear palsy of the
ichardson subtype do normally not display a hypere-
hogenic SN, but rather show increased echogenicity of the
enticular nucleus [5]. In contrast, patients with corticobasal
egeneration commonly display a hyperechogenic SN in com-
ination with hyperechogenicity in the lenticular nucleus
11].
ther movement disorders
n clinical practice, B-mode sonography proved also to be
seful for discrimination of IPS from other movement or gait
isorders, such as normal pressure hydrocephalus or other
isorders associated with metal accumulation in the basal
anglia.
B-mode sonography allows the visualization of the ven-
ricular system, especially the third ventricle and the side
entricles. Thus, in patients with an unclear gait disorder
he differential diagnosis of a normal pressure hydro-
ephalus can be ruled out easily [12]. Due to the fact,
hat iron accumulation is proposed to be the anatomical
orrelation of the SN hyperechogenicity in Parkinson’s dis-
ase, TCS was also studied in other movement disorders
elated to metal accumulation. For example, it was found,
hat the lenticular nucleus displays increased echogenic
alues in patients suffering from Wilson’s disease, a dis-
rder with copper accumulation in and outside the brain.
he intensity of hyperechogenicity correlates with disease
everity [13]. In patients with cervical and upper limb dys-
onia TCS displays increased lenticular nucleus echogenicity
ronounced contra lateral to the clinically affected side
14,15]. As hyperechogenicity in the parenchymal sonog-
aphy was believed to be due to metal accumulation, a
ost mortem analysis was performed in individuals suffering
rom dystonia. This study could rule out an increased copper
nd manganese content in the lenticular nucleus compared
o controls [16]. Recently, our group was able to show,
hat patients suffering from neurodegeneration with brain
ron accumulation (NBIA), a disease with childhood onset
hich is caused by mutations in enzymes dealing with iron
etabolism in the brain, also shows increased echogenicity
n the SN compared to healthy controls [17].
Taken together, TCS seems to be a valid tool in the dif-
erential diagnosis of movement disorders, especially if they
re related to metal accumulation in the brain. In com-
arison to MRI ﬁndings especially in patients suffering from
ilson’s disease and NBIA, it has to be critically noted that
he sonographic ﬁndings do concur, but especially within
he basal ganglia. MRI scans by far show more affected
reas than sonography does [18] [19]. For example in Wil-
on’s disease, T2-weighted MR images show decreased signal
ntensities in the globus pallidus, putamen, substantia nigra,
nd caudate nuclei, while TCS only veriﬁes changes in the
enticular nucleus. Similar to Wilson’s disease, T2*-weighted
cans in NBIA show hypointensities within the globus pal-
idus, SN, putamen and the dentate nucleus. It is not clear
o far, why not all signal abnormalities documented by MRI
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an be reproduced by TCS. One reason may be higher sen-
itivity of MRI in the detection of metal deposition. On the
ontrary, changes seen in the SN by TCS in PD in our expe-
ience occur earlier than those seen by MRI. In conclusion,
ne may speculate, that the sensitivity of TCS differs in var-
ous brain regions with some shortcomings within the basal
anglia region.
ovement disorders in children
n the pediatric ﬁeld, besides CCT and cMRI, transcranial
ltrasound is already used routinely for several years due
o its advantages regarding radiation exposure and the abil-
ty to examine the children without sedation. The American
cademy of Neurology and the Practice Committee of the
hild Neurology Society thus recommend the use of TCS for
eonates with an increased risk for intraventricular hem-
rrhage, preterm white matter injury or ventriculomegaly
20]. However until now routine use of ultrasound in chil-
ren and adolescents with movement disorders is not widely
pplied. In light of the TCS ﬁndings gained from studies in
dult patients with movement disorders we will highlight
n the following three diseases displaying TCS abnormali-
ies in adults with disease onset already during childhood or
dolescence. As already mentioned above, Wilson’s disease
s a disorder with copper storage abnormalities throughout
he body and also in the basal ganglia due to mutations
n the copper transport ATPase [21]. Besides other symp-
oms, accumulation of copper in the brain leads to dystonia,
remor and akinetic-rigid symptoms with the age of man-
festation ranging from 7 to 37 years of age. Some cases
ave been reported though with even earlier onset at pre-
chool age [22,23]. The broad range of symptoms, which
ccur during disease course can cause difﬁculties in the early
iagnosis. Prashanth et al. analysed the clinical data of Wil-
on’s disease patients which were registered over 30 years
nd found a mean time delay from disease onset to diagnosis
f two years with a range from 0.08—30 years [24]. Besides
linical experience and education, these data underline the
eed for diagnostic modalities in the early diagnosis of this
isorder. As the MRI displays typical signs (e.g. ‘‘face of the
iant panda’’ and the ‘‘bright claustrum’’) in this disease,
t appears as one of the most important diagnostic tools in
ifferential diagnosis. However, especially in children, MRI
xamination is laborious and most of the children need seda-
ion [18]. This is, besides the costs, a limiting factor of this
ethod and highlights the necessity for the implementation
f a screening method. Walter et al. demonstrated typical
hanges in the lenticular nucleus by TCS with increasing
chogenicity depending on the disease activity in Wilson’s
isease patients [13]. These results raise the hope, that TCS
an be useful as a screening method in addition to copper
nd ceruloplasmin analysis in serum.
A second movement disorder with adolescent onset is
riedreich’s ataxia. It is the most common among the
nherited ataxias in Europe. The main clinical features are
ysarthria, pyramidal tract damage and progressive ataxia
25]. The ﬁrst clinical symptoms of Friedreich’s ataxia nor-
ally appear during puberty, but also early and late onset
ariants exist [25]. To date, the diagnosis is based on clinical
xamination, supported by electrophysiological ﬁndings and
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[14] Naumann M, Becker G, Toyka KV, Supprian T, Reiners K.Transcranial ultrasound in adults and children with moveme
proven by genetic analysis with conﬁrmation of a GAA expan-
sion within the ﬁrst exon of the Frataxin gene [26]. Recently
Synofzik et al. published their study, which examined TCS
in patients suffering from Friedreich’s ataxia. Interestingly
they could show hyperechogenic changes in the dentate
nucleus, which was present in 85% of all patients and already
visible after short disease duration [27]. This ﬁnding was
accompanied by a hypoechogenic SN. One possible expla-
nation for the hyperechogenicity of the dentate nucleus as
discussed by the authors is an increased iron content, which
is also detectable on T2*-weighted MRI images [28]. The
authors see TCS useful for assessment of patients suffer-
ing from ataxia. One shortcoming is, that dentate nucleus
hyperechogenicity is not speciﬁc for Friedreich’s ataxia, but
was also found in patients suffering from spinocerebellar
ataxia type 3 (SCA3) [29]. In contrast to Friedreich’s patients
though, the hyperechogenicity appeared less frequent (54%)
and in combination with SN hyperechogenicity (40%). Taken
together, these two studies provide evidence for the use-
fulness of TCS in the differential diagnosis of ataxias, but
further studies are needed to validate these data, especially
a direct comparison of patients with Friedreich’s ataxia to
those suffering from SCA3 are needed to rule out the real
diagnostic potential of TCS.
Neurodegeneration with brain iron accumulation, for-
merly known as Hallervorden—Spatz syndrome is a move-
ment disorder with early onset and a wide range of initial
neurological symptoms. The estimated prevalence is 1—3
per million. Neuropathological hallmarks are abnormal iron
accumulations especially in the globus pallidus and the sub-
stantia nigra pars reticulata. Recently, mutations in the
pantothenate kinase 2 (PANK2) gene were identiﬁed as
causative for up to 70% of all NBIA cases. Hence, this sub-
type of NBIA was designated pantothenate kinase-associated
neurodegeneration (PKAN) [30,31]. The ﬁrst symptoms usu-
ally occur during childhood and patients initially present
with walking difﬁculties. Later the typical symptoms con-
sisting of dysarthria, dystonia and visual problems occur
[32]. To date, the diagnosis is obtained using MR imaging
showing the pathognomonic hypointensity within the globus
pallidus along with high signal intensity in the center of
the globus pallidus internus also known as ‘‘eye-of-the-
tiger-sign’’ (EOT-sign) on T2-weighted images [33]. The
veriﬁcation of the diagnosis is done by documentation of
PANK2 mutation. As the clinical presentation of patients
can be unspeciﬁc and the MR imaging implies sedation in
children, we recently performed a study examining the diag-
nostic properties of TCS in the diagnosis of NBIA. In this small
study, 7 patients were examined by transcranial ultrasound
and the results were compared to age matched controls
without any history of neurological disease [17]. Interest-
ingly, we found a highly signiﬁcant hyperechogenicity of the
SN in NBIA patients. Surprisingly, we were not able to detect
valid changes within the basal ganglia, which in MRI usually
display the pathognomonic EOT sign. As already discussed
for Wilson’s disease, further studies and more experience
are needed to evaluate this shortcoming of TCS in the area
of the basal ganglia. Due to the limited size of our study the
ﬁndings need to be reproduced in a bigger cohort of patients.
Nevertheless, it provides good evidence for the usefulness
of TCS especially in children with suspected movement dis-
orders prior to genetic testing or MR imaging.sorders 351
onclusion
ince the initial ﬁnding by Becker and co-workers, that TCS
s capable of displaying changes in the SN in PD patients,
he application of this method in the early and differen-
ial diagnosis of Parkinson related movement disorders is
lready part of the basic diagnostics in the clinical setting.
o date, intensive research is examining the properties of
his method in various diseases, especially in those where
etal accumulation is causative or a result of the disor-
er. Unfortunately, this research usually is performed and
ocussed on adults. Because of the simplicity of this method,
he ability to use it in patients without sedation and the lack
f side effects a broader application is desirable with special
ocus on the pediatric ﬁeld.
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